Literature DB >> 7327083

Diazepam use among methadone maintenance patients: patterns and dosages.

M L Stitzer, R R Griffiths, A T McLellan, J Grabowski, J W Hawthorne.   

Abstract

Methadone maintenance patients who use benzodiazepine drugs were interviewed about the dosage levels, patterns, frequency and motives for their use of these drugs. The sample was drawn from two treatment clinics, one in Baltimore (N = 12) and one in Philadelphia (N = 17). Benzodiazepine use was prevalent at both of these clinics - 65 -70% of maintenance patients had positive urinalysis tests during a single month. Ninety-three per cent of survey participants identified diazepam as the drug which they used most often. The median value of the usual daily dose was 40 - 45 mg; 31% reported usual daily doses between 70 and 300 mg and 62% had experience with doses of 100 mg and higher. The majority of the sample reported taking diazepam in a single daily dose within one hour of the time that they ingested their daily methadone; 72% of the sample indicated that diazepam boosts the effects obtained from the daily methadone dose. Another sample of addicts who reported extensive experience with both benzodiazepines and barbiturates indicated that diazepam increases the effects of methadone while barbiturates produce no change in the effects of methadone. Results of this study suggest that patterns and dosages of diazepam use among methadone maintenance patients are primarily abusive rather than therapeutic.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7327083     DOI: 10.1016/0376-8716(81)90061-2

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  24 in total

1.  Risk factors associated with benzodiazepine use among people who inject drugs in an urban Canadian setting.

Authors:  Devin Tucker; Kanna Hayashi; M-J Milloy; Seonaid Nolan; Huiru Dong; Thomas Kerr; Evan Wood
Journal:  Addict Behav       Date:  2015-10-09       Impact factor: 3.913

Review 2.  Methadone maintenance in the treatment of opioid dependence. A current perspective.

Authors:  J E Zweben; J T Payte
Journal:  West J Med       Date:  1990-05

3.  A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers.

Authors:  M Farré; M T Terán; J Camí
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

4.  Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers.

Authors:  James P Zacny; Judith A Paice; Dennis W Coalson
Journal:  Drug Alcohol Depend       Date:  2012-02-25       Impact factor: 4.492

5.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

6.  Preference for an Opioid/Benzodiazepine Mixture over an Opioid Alone Using a Concurrent Choice Procedure in Rhesus Monkeys.

Authors:  Peter F Weed; Charles P France; Lisa R Gerak
Journal:  J Pharmacol Exp Ther       Date:  2017-04-24       Impact factor: 4.030

7.  Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder.

Authors:  R Kathryn McHugh; Victoria R Votaw; Olivera Bogunovic; Sterling L Karakula; Margaret L Griffin; Roger D Weiss
Journal:  Addict Behav       Date:  2016-08-18       Impact factor: 3.913

8.  Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects.

Authors:  R R Griffiths; D R McLeod; G E Bigelow; I A Liebson; J D Roache
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 9.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

10.  Clinical evaluation and use of urine screening for drug abuse.

Authors:  A J Saxon; D A Calsyn; V M Haver; C J Delaney
Journal:  West J Med       Date:  1988-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.